These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21707926)

  • 21. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
    Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
    J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials.
    Wang C; Stephens-Shields AJ; DeRogatis LR; Cunningham GR; Swerdloff RS; Preston P; Cella D; Snyder PJ; Gill TM; Bhasin S; Matsumoto AM; Rosen RC
    J Sex Med; 2018 Jul; 15(7):997-1009. PubMed ID: 29960633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR; Graziottin A; Bitzer J; Schmitt S; Koochaki PE; Rodenberg C
    J Sex Med; 2009 Jan; 6(1):175-83. PubMed ID: 19170847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Predictors of Low Sexual Desire, Sexually Related Personal Distress, and Hypoactive Sexual Desire Dysfunction in a Community-Based Sample of Midlife Women.
    Worsley R; Bell RJ; Gartoulla P; Davis SR
    J Sex Med; 2017 May; 14(5):675-686. PubMed ID: 28499520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
    Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
    J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of hypoactive sexual desire disorder (HSDD) in men.
    DeRogatis L; Rosen RC; Goldstein I; Werneburg B; Kempthorne-Rawson J; Sand M
    J Sex Med; 2012 Mar; 9(3):812-20. PubMed ID: 22239825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.
    Amsterdam JD; Brunswick DJ; Gibertini M
    J Psychiatr Res; 2004; 38(3):259-65. PubMed ID: 15003431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z; Yang D; Yu L; Cui Y
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of sexual dysfunction during acute treatment of major depression with milnacipran.
    Baldwin D; Moreno RA; Briley M
    Hum Psychopharmacol; 2008 Aug; 23(6):527-32. PubMed ID: 18536065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study.
    Muin DA; Sheikh Rezaei S; Tremmel-Scheinost M; Salama M; Luger A; Wolzt M; Husslein PW; Bayerle-Eder M
    Fertil Steril; 2017 Mar; 107(3):781-787.e3. PubMed ID: 28189292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone.
    Robinson DS; Sitsen JM; Gibertini M
    Clin Ther; 2003 Jun; 25(6):1618-33. PubMed ID: 12860488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.
    Sills T; Wunderlich G; Pyke R; Segraves RT; Leiblum S; Clayton A; Cotton D; Evans K
    J Sex Med; 2005 Nov; 2(6):801-18. PubMed ID: 16422805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
    Kennedy S
    J Sex Med; 2010 Oct; 7(10):3449-59. PubMed ID: 20646181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presentation of hypoactive sexual desire disorder in premenopausal women.
    Maserejian NN; Shifren JL; Parish SJ; Braunstein GD; Gerstenberger EP; Rosen RC
    J Sex Med; 2010 Oct; 7(10):3439-48. PubMed ID: 20646184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.
    Clayton AH; Hwang E; Kornstein SG; Tourian KA; Cheng RF; Abraham L; Mele L; Boucher M
    Int Clin Psychopharmacol; 2015 Nov; 30(6):307-15. PubMed ID: 26230270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of major depression with sexual dysfunction in men.
    Fabre LF; Clayton AH; Smith LC; Goldstein IM; Derogatis LR
    J Neuropsychiatry Clin Neurosci; 2013; 25(4):308-18. PubMed ID: 23645187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties.
    Kaur Gill A; Bansal Y; Bhandari R; Kaur S; Kaur J; Singh R; Kuhad A; Kuhad A
    Drugs Today (Barc); 2019 Jul; 55(7):423-437. PubMed ID: 31347611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
    Pae CU; Masand PS; Marks DM; Krulewicz S; Han C; Peindl K; Mannelli P; Patkar AA
    World J Biol Psychiatry; 2009; 10(4 Pt 2):435-41. PubMed ID: 19382010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.